Is it appropriate to select patients for primary prophylactic use of pegfilgrastim based on the risk of febrile neutropenia?
Saved in:
| Title: | Is it appropriate to select patients for primary prophylactic use of pegfilgrastim based on the risk of febrile neutropenia? |
|---|---|
| Authors: | Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-Cho, Minami-Ku, Yokohama, Kanagawa, 232-0024, Japan. nr1@gc5.so-net.ne.jp., Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan., Takashima I; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan., Kashiwabara K; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan., Uemura Y; Department of Data Science, National Center for Global Health and Medicine, Tokyo, Japan., Kikawa Y; Department of Breast Surgery, Kansai Medical University, Osaka, Japan., Taira N; Department of Breast Surgery, Kawasaki Medical School, Okayama, Japan., Mukai H; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. |
| Source: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2025 May 07; Vol. 33 (6), pp. 456. Date of Electronic Publication: 2025 May 07. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1433-7339 |
|---|---|
| DOI: | 10.1007/s00520-025-09514-6 |
